Literature DB >> 25131860

Expression and biochemical characterization of recombinant human epididymis protein 4.

Ling Hua1, Yunhui Liu2, Shuai Zhen2, Deyou Wan2, Jiyue Cao3, Xin Gao4.   

Abstract

Whey acidic proteins (WAP) belong to a large gene family of antibacterial peptides that perform critical immune system functions. The function of human epididymis protein 4 (HE4), a 124-amino acid long polypeptide that has two whey acidic protein four-disulfide core (WFDC) domains, is not well studied. Here, a fusion gene encoding the HE4 protein fused to an IgG1 Fc domain was constructed. The recombinant HE4 protein was expressed as a secretory protein in Pichia pastoris and mammalian HEK293-F cells and was subsequently purified. Our data suggested that the HE4 protein produced by these two expression systems bound to both gram-negative and gram-positive bacteria, but demonstrated slightly inhibitory activity towards the growth of Staphylococcus aureus. Moreover, HE4 exhibited proteinase inhibitory activity towards trypsin, elastase, matrix metallopeptidase 9, and the secretory proteinases from Bacillus subtilis. The effects of glycosylation on the biochemical characterization of HE4 were also investigated. LC-ESI-MS glycosylation analysis showed that the high-mannose glycosylated form of HE4 expressed by P. pastoris has lower biological activity when compared to its complex-glycosylated form produced from HEK293-F cells. The implications of this are discussed, which may be provide theoretical basis for its important role in the development of cancer and innate immune system.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial activity; Antiprotease activity; N-glycosylation; Recombinant human epididymis protein 4

Mesh:

Substances:

Year:  2014        PMID: 25131860     DOI: 10.1016/j.pep.2014.08.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Human epididymis protein 4 may not be a reliable screening biomarker for detecting lung carcinoma patients.

Authors:  Betul Celik; Tangul Bulut
Journal:  Biomed Rep       Date:  2017-08-25

2.  The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.

Authors:  Nicole E James; Jenna B Emerson; Ashley D Borgstadt; Lindsey Beffa; Matthew T Oliver; Virginia Hovanesian; Anze Urh; Rakesh K Singh; Rachael Rowswell-Turner; Paul A DiSilvestro; Joyce Ou; Richard G Moore; Jennifer R Ribeiro
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

Review 3.  Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.

Authors:  Manikandan Muthu; Sechul Chun; Judy Gopal; Vimala Anthonydhason; Steve W Haga; Anna Jacintha Prameela Devadoss; Jae-Wook Oh
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

Review 4.  Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.

Authors:  Alan Kirwan; Marta Utratna; Michael E O'Dwyer; Lokesh Joshi; Michelle Kilcoyne
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

5.  A Systematic Analysis of the Structures of Heterologously Expressed Proteins and Those from Their Native Hosts in the RCSB PDB Archive.

Authors:  Ren-Bin Zhou; Hui-Meng Lu; Jie Liu; Jian-Yu Shi; Jing Zhu; Qin-Qin Lu; Da-Chuan Yin
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.